Epygen is a biotechnology organization, headquartered in Dubai, UAE, with offices, labs and manufacturing facilities in Dubai, India, and the US.

Epygen is a biotechnology organization, headquartered in Dubai, UAE, with offices, labs and manufacturing facilities in Dubai, India, and the US.

STREPTOKINASE is a bacterial protein, produced by several species of streptococci, that dissolves the human blood clots. It is a potent activator of plasminogen, the inactive precursor of plasmin.

More affordable version of therapeutic protein recombinant Streptokinase to address over a million ST elevated Micardial Infraction (STEMI) deaths in part of the world where affordability is the key.

The oil game is still played very traditionally in the Middle East, but companies such as Dubai’s biotech firm Epygen Labs are slowly encouraging the sector to rethink the old ways.

At one of Asia’s leading Pulp and Paper technology shows held in Jakarta during April 2015, Epygen presented it’s innovative Enzymatic concept to treat recycled fiber under highly closed white water system prevailing in Middle East and North African region.

Epygen received overwhelming response at the the Life Sciences Career Fair held at Dubiotech Lab Complex on 26th March 2015.

Economical oil recovery NOCS are increasingly looking to small, agile research and development firms to deliver innovative approaches to enhanced oil recovery.

According to the WHO, amongst all non-communicable diseases, cardiovascular disease (CVD) is the major cause of death in both developed and developing countries. In the year […]

Epygen is pleased to announce opening of a state of art, Biotech incubation facility at Navi Mumbai, India. This consists of a full- fledged Bioprocessing Pilot […]